Page last updated: 2024-08-21

quinazolines and bp-1-102

quinazolines has been researched along with bp-1-102 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chu, P; Lou, M; Wang, Z; Yin, M	1

Other Studies

1 other study(ies) available for quinazolines and bp-1-102

Article	Year
STAT3 inhibitor sensitized KRAS-mutant lung cancers to RAF inhibitor by activating MEK/ERK signaling pathway. Aging, 2019, 09-04, Volume: 11, Issue:17 Topics: Aminosalicylic Acids; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mice, Inbred BALB C; Mice, Nude; Proto-Oncogene Proteins p21(ras); Quinazolines; raf Kinases; STAT3 Transcription Factor; Sulfonamides	2019

Article

Year

STAT3 inhibitor sensitized KRAS-mutant lung cancers to RAF inhibitor by activating MEK/ERK signaling pathway.

Aging, 2019, 09-04, Volume: 11, Issue:17

Topics: Aminosalicylic Acids; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mice, Inbred BALB C; Mice, Nude; Proto-Oncogene Proteins p21(ras); Quinazolines; raf Kinases; STAT3 Transcription Factor; Sulfonamides

2019